Rituximab in the Treatment of Graves' Disease

Clinical trial NCT00150111 · COMPLETED

Trial details

NCT number: NCT00150111
Sponsor: Odense University Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Graves´ Disease Thyroid Associated Ophthalmopathy

Start date: 2003-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.